- Home
- EBMT vs KOD Comparison
EBMT vs KOD Comparison
Compare EBMT & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- KOD
- Stock Information
- Founded
- EBMT 1922
- KOD 2009
- Country
- EBMT United States
- KOD United States
- Employees
- EBMT N/A
- KOD N/A
- Industry
- EBMT Major Banks
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EBMT Finance
- KOD Health Care
- Exchange
- EBMT Nasdaq
- KOD Nasdaq
- Market Cap
- EBMT 139.5M
- KOD 186.3M
- IPO Year
- EBMT N/A
- KOD 2018
- Fundamental
- Price
- EBMT $15.64
- KOD $8.72
- Analyst Decision
- EBMT
- KOD Hold
- Analyst Count
- EBMT 0
- KOD 5
- Target Price
- EBMT N/A
- KOD $6.80
- AVG Volume (30 Days)
- EBMT 15.1K
- KOD 473.7K
- Earning Date
- EBMT 01-21-2025
- KOD 11-14-2024
- Dividend Yield
- EBMT 3.66%
- KOD N/A
- EPS Growth
- EBMT N/A
- KOD N/A
- EPS
- EBMT 1.09
- KOD N/A
- Revenue
- EBMT $80,038,000.00
- KOD N/A
- Revenue This Year
- EBMT N/A
- KOD N/A
- Revenue Next Year
- EBMT $8.40
- KOD N/A
- P/E Ratio
- EBMT $14.38
- KOD N/A
- Revenue Growth
- EBMT N/A
- KOD N/A
- 52 Week Low
- EBMT $12.32
- KOD $2.19
- 52 Week High
- EBMT $17.65
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- EBMT 26.50
- KOD 64.72
- Support Level
- EBMT $15.48
- KOD $8.03
- Resistance Level
- EBMT $17.05
- KOD $9.55
- Average True Range (ATR)
- EBMT 0.39
- KOD 0.89
- MACD
- EBMT -0.21
- KOD -0.08
- Stochastic Oscillator
- EBMT 7.48
- KOD 36.51
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.